Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-009-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
In a GLP study conducted in compliance with OECD guideline 429 with d-limonene in ethanol/diethyl phthalate, an EC3 value of 22% was obtained.
In an study conducted similarly to OECD guideline 429 with limonene in acetone/olive oil, an EC3 value of 68.5% was obtained.
In an study conducted similarly to OECD guideline 429 with beta-phellandrene in acetone/olive oil, an EC3 value of 5.6% was obtained.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Justification for type of information:
- D-Limonene is one of the main constituents of multiconstituent substance REACTION MASS OF BETA-PHELLANDRENE AND D-LIMONENE AND L-LIMONENE. Therefore, data on d-limonene can be used for extrapolation to REACTION MASS OF BETA-PHELLANDRENE AND D-LIMONENE AND L-LIMONENE. See read-across justification document in section 13.
- Reason / purpose for cross-reference:
- read-across source
- Positive control results:
- Mean DPM
- Vehicle (acetone/olive oil 4:1 v/v) = 2263
- Test material (5 % w/v) = 5496
- Test material (10 % w/v) = 7571
- Test material (25 % w/v) = 24752
Stimulation Index
- Test material (5 % w/v) = 2.4
- Test material (10 % w/v) = 3.3
- Test material (25 % w/v) = 10.9 - Key result
- Parameter:
- SI
- Remarks on result:
- other: - Test material (10% v/v) = 1.3 - Test material (25% v/v) = 3.4 - Test material (50% v/v) = 4.0 - Test material (75% v/v) = 8.8 - Test material (100% v/v) = 6.5
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: - Vehicle = 2511 - Test material (10% v/v) = 3319 - Test material (25% v/v) = 8554 - Test material (50% v/v) = 9916 - Test material (75% v/v) = 22063 - Test material (100% v/v) = 16259
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- d-Limonene is classified as ‘R43 May cause sensitisation by skin contact’, according toDirective 67/548/EEC and in ‘Category 1’ according to CLP Regulation (EC) No 1272/2008.
- Executive summary:
In a local lymph node assay performed in CBA/Ca strain mice according to OECD guideline 429 and in compliance with GLP, groups of mice (4 females/dose) were applied with 25 µL of d-limonene at concentrations of 0 (vehicle control), 10, 25, 50, 75 or 100% v/v in ethanol/diethyl phthalate (3: 1 v/v) to the dorsal surface of each ear for three consecutive days. On Day 6, all animals were injected with 3H-methyl thymidine and after five hours the draining (auricular) lymph nodes were excised and measured for radioactivity expressed as number of disintegrations per minute (DPM). Historic data of hexylcinnamaldehyde (5, 10 and 25 % w/v) in acetone/olive oil (4:1 v/v) was used as the data for the positive control group.
Mean DPM for 0, 10, 25, 50, 75 or 100% d-limonene were observed to be 2511, 3319, 8554, 9916, 22063 or 16259 dpm, respectively. Stimulation index for 10, 25, 50, 75 or 100% of d-limonene were calculated to be 1.3, 3.4, 4.0, 8.8 or 6.5, respectively. The estimated concentration giving rise to a 3 fold increase in lymphocyte proliferation (EC3) was 22% v/v (5500 µg/cm2). No increase in visual levels of irritancy to the ear skin was observed during the study.
Therefore, d-limonene is classified as ‘R43 May cause sensitisation by skin contact’, according to Directive 67/548/EEC and in ‘Category 1’ according to CLP Regulation (EC) No 1272/2008.
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Justification for type of information:
- D-Limonene is one of the main constituents of multiconstituent substance REACTION MASS OF BETA-PHELLANDRENE AND D-LIMONENE AND L-LIMONENE. Therefore, data on d-limonene can be used for extrapolation to REACTION MASS OF BETA-PHELLANDRENE AND D-LIMONENE AND L-LIMONENE. See read-across justification document in section 13.
- Reason / purpose for cross-reference:
- read-across source
- Positive control results:
- Not applicable
- Key result
- Parameter:
- SI
- Remarks on result:
- other: 1, 1.84, 2.44 and 3.95 at 0, 25, 50 and 100% v/v, respectively
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: 476, 877, 1164 and 1882 at 0, 25, 50 and 100% v/v, respectively
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- The calculated EC3-value for d-limonene was found to be 68.5%. Therefore, d-limonene was found to be sensitising and should be clasified as skin sensitiser according to Directive 67/548/EEC and CLP Regulation (EC) No 1272/2008.
- Executive summary:
In a skin sensitization study conducted following a method similar to OECD guidelines 429, four groups of CBA/Ca strain female mice (4/concentration) were exposed topically on the dorsum of both ears to 25 µL of vehicle (acetone/olive oil, 4:1 v/v), 25, 50 and 100% v/v of d-limonene daily for 3 consecutive days. Five days following initiation of exposure all mice were injected 250 µL of phosphate buffered saline (PBS) containing 20 µCi of [3H] methyl thymidine (3H-TdR). The animals were then sacrificed after 5 hours and suspension of lymph node cells was prepared from auricular lymph nodes. The incorporation of 3H-TdR was measured by β-scintillation counting as disintegrations per minute (dpm) per node for each experimental group. A Stimulation Index of 3 or greater was considered to be indicative of a potential to cause contact sensitization.
d-Limonene at exposure concentration of 0 (vehicle), 25, 50 and 100% v/v resulted in 476, 877, 1164 and 1882 dpm/node and stimulation index of 1, 1.84, 2.44 and 3.95, respectively.
The calculated EC3-value for d-limonene was found to be 68.5%. Therefore, d-limonene was found to be sensitising and should be clasified as skin sensitiser according to Directive 67/548/EEC and CLP Regulation (EC) No 1272/2008.
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Justification for type of information:
- Beta-phellandrene is one of the main constituents of multiconstituent substance REACTION MASS OF BETA-PHELLANDRENE AND D-LIMONENE AND L-LIMONENE. Therefore, data on beta-phellandrene can be used for extrapolation to REACTION MASS OF BETA-PHELLANDRENE AND D-LIMONENE AND L-LIMONENE. See read-across justification document in section 13.
- Reason / purpose for cross-reference:
- read-across source
- Principles of method if other than guideline:
- Not applicable
- Positive control results:
- EC3 values of cinnamic alcohol and cinnamic aldehyde were 1.5 M (20.1%) and 0.10 M (1.3%), respectively.
- Key result
- Parameter:
- EC3
- Remarks:
- in % w/v
- Value:
- 5.6
- Cellular proliferation data / Observations:
- Refer Table 7.4.1/1
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The test material is classified as skin sensitiser, sub-category 1B, according to the GHS and CLP Regulation (EC) No 1272/2008.
- Executive summary:
In a local lymph node assay, groups of mice (4/dose) were exposed to the test material at concentrations of 0 (vehicle control), 1, 10 or 20% w/v. Results were expressed as mean dpm/lymph node for each experimental group and as stimulation index (SI), i.e., test group/control group ratio. EC3 value (the estimated concentration required to induce an SI of 3) was calculated by linear interpolation.
At 0, 1, 10 and 20% w/v of the test material, the mean [3H]thymidine incorporation (dpm/lymph node) were noted to be 478, 540, 2283 and 10964, respectively. Stimulation index at 1, 10 and 20% w/v of the test material was determined to be 1.1, 4.8 and 23, respectively, and the EC3 was calculated to be 5.6% w/v (0.41 M). The EC3 values of positive controls cinnamic alcohol and cinnamic aldehyde were reported to be 1.5 (20.1%) and 0.10 M (1.3%), respectively.
Therefore, the test material is classified as skin sensitiser, sub-category 1B, according to the GHS and CLP Regulation (EC) No 1272/2008.
Referenceopen allclose all
Dermal reactions: Application of the test substance did not result in an increase in visual levels of irritancy to the skin on or around the ear area for the duration of the study.
Table 1 - Skin sensitisation potential of d-limonene in ethanol/diethyl phthalate (3:1 v/v)
Concentration of test substance (% v/v) |
Number of lymph nodes assayed |
Disintegrations per min (dpm) |
dpm per lymph node |
Test:control ratio |
0 (vehicle only) |
8 |
2511 |
314 |
Not applicable |
10 |
8 |
3319 |
415 |
1.3 |
25 |
8 |
8554 |
1069 |
3.4 |
50 |
8 |
9916 |
1240 |
4.0 |
75 |
8 |
22063 |
2758 |
8.8 |
100 |
8 |
16259 |
2032 |
6.5 |
EC3 |
Estimated to be 22% (5500 µg/cm2) |
Table 2 - Skin sensitisation potential of the positive control substance (hexylcinnamaldehyde)
Concentration of hexylcinnamaldehyde (% w/v) |
Number of lymph nodes assayed |
Disintegrations per min (dpm) |
dpm per lymph node |
Test:control ratio |
0 (vehicle only) |
8 |
2263 |
283 |
Not applicable |
5 |
8 |
5496 |
687 |
2.4 |
10 |
8 |
7571 |
946 |
3.3 |
25 |
8 |
24752 |
3094 |
10.9 |
Table 1: Local lymph node assay responses to limonene
Exposure Concentration (% v/v) |
dpm/node |
Stimulation index (SI) |
EC3 (%) |
0 |
476 |
1 |
68.5 |
25 |
877 |
1.84 |
|
50 |
1164 |
2.44 |
|
100 |
1882 |
3.95 |
Table 7.4.1/1: LLNA responses
Test concentration (% w/v) |
[3H]thymidine incorporation (dpm/lymph node) |
SI |
EC3 value |
Classification |
|
% w/v |
M |
||||
0 |
478 |
5.6 |
0.41 |
Moderate |
|
1 |
540 |
1.1 |
|||
10 |
2283 |
4.8 |
|||
20 |
10964 |
23 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In a local lymph node assay performed in CBA/Ca strain mice according to OECD Guideline 429 and in compliance with GLP, 25 µL of d-limonene were applied to the dorsal surface of each ear of groups of mice (4 females/dose) at concentrations of 0 (vehicle control), 10, 25, 50, 75 or 100% v/v in ethanol/diethyl phthalate (3: 1 v/v) for three consecutive days. On Day 6, all animals were injected with 3H-methyl thymidine and after five hours the draining (auricular) lymph nodes were excised and radioactivity was measured expressed as number of disintegrations per minute (DPM). Historic data of hexylcinnamaldehyde (5, 10 and 25 % w/v) in acetone/olive oil (4:1 v/v) was used as the data for positive control group. Mean DPM for 0, 10, 25, 50, 75 or 100% d-limonene were observed to be 2511, 3319, 8554, 9916, 22063 or 16259 dpm, respectively. Stimulation index for 10, 25, 50, 75 or 100% d-limonene were calculated to be 1.3, 3.4, 4.0, 8.8 or 6.5, respectively. The estimated concentration giving rise to a 3 fold increase in lymphocyte proliferation (EC3) was 22% v/v (5500 µg/cm2). No increase in visual levels of irritancy to the ear skin was observed during the study.
In a skin sensitization study conducted following a method similar to OECD Guideline 429, four groups of CBA/Ca strain female mice(4 females/dose) were exposed topically on the dorsum of both ears to 25 µL of vehicle (acetone/olive oil, 4:1 v/v), 25, 50 and 100% v/v of d-limonene daily for 3 consecutive days. Five days following initiation of exposure all mice were injected 250 µL of phosphate buffered saline (PBS) containing 20 µCi of [3H] methyl thymidine (3H-TdR). The animals were then sacrificed after 5 hours and suspension of lymph node cells was prepared from auricular lymph nodes. The incorporation of 3H-TdR was measured by β-scintillation counting as disintegrations per minute (dpm) per node for each experimental group. A Stimulation index of 3 or greater was considered to be indicative of a potential to cause contact sensitization.
d-Limonene at exposure concentration of 0 (vehicle), 25, 50 and 100% v/v resulted in 476, 877, 1164 and 1882 dpm/node and stimulation index of 1, 1.84, 2.44 and 3.95, respectively. The calculated EC3-value for d-limonene was found to be 68.5%.
In a local lymph node assay, groups of mice (4/dose) were exposed to beta-phellandrene at concentrations of 0 (vehicle control), 1, 10 or 20% w/v. Results were expressed as mean dpm/lymph node for each experimental group and as stimulation index (SI), i.e., test group/control group ratio. EC3 value (the estimated concentration required to induce an SI of 3) was calculated by linear interpolation. At 0, 1, 10 and 20% w/v of the test material, the mean [3H]thymidine incorporation (dpm/lymph node) were noted to be 478, 540, 2283 and 10964, respectively. Stimulation index at 1, 10 and 20% w/v of the test material was determined to be 1.1, 4.8 and 23, respectively, and the EC3 was calculated to be 5.6% w/v (0.41 M). The EC3 values of positive controls cinnamic alcohol and cinnamic aldehyde were reported to be 1.5 (20.1%) and 0.10 M (1.3%), respectively.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
d-Limonene and beta-phellandrene were found to be skin sensitisers and should be classified as skin sensitisers category 1B according to the criteria of CLP Regulation (EC) No 1272/2008. As the registered substance contains more than 1% w/w of d-limonene and beta-phellandrene, which are the main constituents of the registered substance, it should also be classified as skin sensitiser category 1B according to the criteria of classification for mixtures of CLP Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.